Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Open Access | 10.1172/JCI181599

Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation

Theresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, Ioannis Kourtzelis, Pallavi Subramanian, Peter Mirtschink, Mirko Peitzsch, Klaus Matschke, Sems M. Tugtekin, Tetsuhiro Kajikawa, Xiaofei Li, Anne Steglich, Florian Gembardt, Annika C. Wegner, Christian Hugo, George Hajishengallis, Triantafyllos Chavakis, Andreas Deussen, Vladimir Todorov, and Irakli Kopaliani

Find articles by Failer, T. in: PubMed | Google Scholar

Find articles by Amponsah-Offeh, M. in: PubMed | Google Scholar |

Find articles by Neuwirth, A. in: PubMed | Google Scholar |

Find articles by Kourtzelis, I. in: PubMed | Google Scholar |

Find articles by Subramanian, P. in: PubMed | Google Scholar |

Find articles by Mirtschink, P. in: PubMed | Google Scholar

Find articles by Peitzsch, M. in: PubMed | Google Scholar |

Find articles by Matschke, K. in: PubMed | Google Scholar |

Find articles by Tugtekin, S. in: PubMed | Google Scholar

Find articles by Kajikawa, T. in: PubMed | Google Scholar |

Find articles by Li, X. in: PubMed | Google Scholar |

Find articles by Steglich, A. in: PubMed | Google Scholar

Find articles by Gembardt, F. in: PubMed | Google Scholar |

Find articles by Wegner, A. in: PubMed | Google Scholar

Find articles by Hugo, C. in: PubMed | Google Scholar

Find articles by Hajishengallis, G. in: PubMed | Google Scholar |

Find articles by Chavakis, T. in: PubMed | Google Scholar

Find articles by Deussen, A. in: PubMed | Google Scholar

Find articles by Todorov, V. in: PubMed | Google Scholar |

Find articles by Kopaliani, I. in: PubMed | Google Scholar

Published May 1, 2024 - More info

Published in Volume 134, Issue 9 on May 1, 2024
J Clin Invest. 2024;134(9):e181599. https://doi.org/10.1172/JCI181599.
© 2024 Failer et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published May 1, 2024 - Version history
View PDF

Related article:

Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation
Theresa Failer, … , Vladimir Todorov, Irakli Kopaliani
Theresa Failer, … , Vladimir Todorov, Irakli Kopaliani
Research Article Cardiology Inflammation Article has an altmetric score of 15

Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation

  • Text
  • PDF
Abstract

The causative role of inflammation in hypertension-related cardiovascular diseases is evident and calls for development of specific immunomodulatory therapies. We tested the therapeutic efficacy and mechanisms of action of developmental endothelial locus-1 (DEL-1), an endogenous antiinflammatory factor, in angiotensin II– (ANGII–) and deoxycorticosterone acetate–salt–induced (DOCA-salt–induced) cardiovascular organ damage and hypertension. By using mice with endothelial overexpression of DEL-1 (EC-Del1 mice) and performing preventive and interventional studies by injecting recombinant DEL-1 in mice, we showed that DEL-1 improved endothelial function and abrogated aortic adventitial fibrosis, medial thickening, and loss of elastin. DEL-1 also protected the mice from cardiac concentric hypertrophy and interstitial and perivascular coronary fibrosis and improved left ventricular function and myocardial coronary perfusion. DEL-1 prevented aortic stiffness and abolished the progression of hypertension. Mechanistically, DEL-1 acted by inhibiting αvβ3 integrin–dependent activation of pro-MMP2 in mice and in human isolated aorta. Moreover, DEL-1 stabilized αvβ3 integrin–dependent CD25+FoxP3+ Treg numbers and IL-10 levels, which were associated with decreased recruitment of inflammatory cells and reduced production of proinflammatory cytokines in cardiovascular organs. The demonstrated effects and immune-modulating mechanisms of DEL-1 in abrogation of cardiovascular remodeling and progression of hypertension identify DEL-1 as a potential therapeutic factor.

Authors

Theresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, Ioannis Kourtzelis, Pallavi Subramanian, Peter Mirtschink, Mirko Peitzsch, Klaus Matschke, Sems M. Tugtekin, Tetsuhiro Kajikawa, Xiaofei Li, Anne Steglich, Florian Gembardt, Annika C. Wegner, Christian Hugo, George Hajishengallis, Triantafyllos Chavakis, Andreas Deussen, Vladimir Todorov, Irakli Kopaliani

×

Original citation: J Clin Invest. 2022;132(6):e126155. https://doi.org/10.1172/JCI126155

Citation for this corrigendum: J Clin Invest. 2024;134(9):e181599. https://doi.org/10.1172/JCI181599

The authors recently became aware of 3 errors in the original publication. In Figure 7H, the Vehicle+Fc flow cytometry panel was incorrect. In Figure 9M, the ANGII+DEL-1-FC panel was incorrect. In Figure 10M, the ANGII+DEL-1-RGE-Fc was incorrect. The correct images, provided from the original source data, are shown below.

The authors regret the errors.

Footnotes

See the related article at Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation.

Version history
  • Version 1 (May 1, 2024): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 8 X users
On 1 Facebook pages
30 readers on Mendeley
See more details